.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Cerilliant
Merck
Mallinckrodt
Daiichi Sankyo
Healthtrust
Cantor Fitzgerald
Citi
Fish and Richardson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Medroxyprogesterone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for medroxyprogesterone acetate and what is the scope of medroxyprogesterone acetate patent protection?

Medroxyprogesterone acetate
is the generic ingredient in seven branded drugs marketed by Pharmacia And Upjohn, Sandoz Inc, Teva Pharms Usa, Amarin Pharms, Solvay, Esi , Barr, Duramed Pharms Barr, and Usl Pharma, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Medroxyprogesterone acetate has forty-two patent family members in twenty-nine countries and one supplementary protection certificate in one country.

There are nineteen drug master file entries for medroxyprogesterone acetate. Twenty-three suppliers are listed for this compound.

Pharmacology for medroxyprogesterone acetate

Ingredient-typeProgesterone Congeners
Drug ClassProgestin

Medical Subject Heading (MeSH) Categories for medroxyprogesterone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms BarrMEDROXYPROGESTERONE ACETATEmedroxyprogesterone acetateTABLET;ORAL040311-003Dec 1, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnPROVERAmedroxyprogesterone acetateTABLET;ORAL011839-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Esi CYCRINmedroxyprogesterone acetateTABLET;ORAL081239-001Oct 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnDEPO-PROVERAmedroxyprogesterone acetateINJECTABLE;INJECTION012541-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Sandoz IncMEDROXYPROGESTERONE ACETATEmedroxyprogesterone acetateINJECTABLE;INJECTION078711-001May 20, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
BarrMEDROXYPROGESTERONE ACETATEmedroxyprogesterone acetateTABLET;ORAL040159-003Aug 9, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms BarrMEDROXYPROGESTERONE ACETATEmedroxyprogesterone acetateTABLET;ORAL040311-001Dec 1, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Esi CYCRINmedroxyprogesterone acetateTABLET;ORAL081240-001Oct 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Esi CYCRINmedroxyprogesterone acetateTABLET;ORAL089386-001Sep 9, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl PharmaMEDROXYPROGESTERONE ACETATEmedroxyprogesterone acetateTABLET;ORAL088484-001Jul 26, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: medroxyprogesterone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And UpjohnDEPO-PROVERAmedroxyprogesterone acetateINJECTABLE;INJECTION012541-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacia And UpjohnDEPO-PROVERAmedroxyprogesterone acetateINJECTABLE;INJECTION012541-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: medroxyprogesterone acetate

Country Document Number Estimated Expiration
Argentina098830► Subscribe
Hungary0302021► Subscribe
Hong Kong1054194► Subscribe
TaiwanI256310► Subscribe
South Korea20030020280► Subscribe
China1429101► Subscribe
Argentina029924► Subscribe
Peru13222001► Subscribe
New Zealand522324► Subscribe
Israel152537► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: MEDROXYPROGESTERONE ACETATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0037Belgium► SubscribePRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Colorcon
Express Scripts
Baxter
US Department of Justice
Accenture
Healthtrust
Teva
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot